Low-risk trials for children and pregnant women threatened by unnecessary strict regulations. Does the coming EU Clinical Trial Regulation offer a solution?

Investigator-initiated clinical trials are crucial for improving quality of care for children and pregnant women as they are often excluded from industry-initiated trials. However, trials have become increasingly time-consuming and costly since the EU Clinical Trial Directive entered into force in 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Knaapen, Max, Ploem, Martine Corrette, Kruijt, Maya, Oudijk, Martijn A., van der Graaf, Rieke, Bet, Pierre M., Bakx, Roel, van Heurn, L. W. Ernst, Gorter, Ramon R., van der Lee, Johanna H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351802/
https://www.ncbi.nlm.nih.gov/pubmed/32535715
http://dx.doi.org/10.1007/s00431-020-03715-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351802/
https://www.ncbi.nlm.nih.gov/pubmed/32535715
http://dx.doi.org/10.1007/s00431-020-03715-3

Ejemplares similares